A 7-month multicenter, parallel, double-blind, placebo-controlled comparison of 150-300mg/day of extended-release bupropion hydrochloride and placebo for the prevention of seasonal depressive episodes in subjects with a history of seasonal affective disorder followed by an 8-week observational follow-up phase

Trial Profile

A 7-month multicenter, parallel, double-blind, placebo-controlled comparison of 150-300mg/day of extended-release bupropion hydrochloride and placebo for the prevention of seasonal depressive episodes in subjects with a history of seasonal affective disorder followed by an 8-week observational follow-up phase

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Feb 2017

At a glance

  • Drugs Bupropion (Primary)
  • Indications Seasonal affective disorder
  • Focus Therapeutic Use
  • Acronyms SAD
  • Most Recent Events

    • 12 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top